000 01310 a2200361 4500
005 20250513000201.0
264 0 _c19821216
008 198212s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00254052
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFulton, D S
245 0 0 _aIntrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1982
300 _a285-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCytarabine
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInjections, Spinal
650 0 4 _aKinetics
650 0 4 _aMeningeal Neoplasms
_xdrug therapy
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aPolyamines
_xcerebrospinal fluid
700 1 _aLevin, V A
700 1 _aGutin, P H
700 1 _aEdwards, M S
700 1 _aSeager, M L
700 1 _aStewart, J
700 1 _aWilson, C B
773 0 _tCancer chemotherapy and pharmacology
_gvol. 8
_gno. 3
_gp. 285-91
856 4 0 _uhttps://doi.org/10.1007/BF00254052
_zAvailable from publisher's website
999 _c6896738
_d6896738